Jared S. Hopkins

The company expects to save an additional $1.2 billion from automation, AI and other digital tools.

The Delaware facility will ensure a domestic supply of biologic drugs including the cancer drug Keytruda.

Pfizer on Tuesday reaffirmed its outlook for the year, and announced another round of cost cuts as the beleaguered drugmaker looks to turn around its business post-pandemic.

Gilead Sciences said Wednesday it will invest $11 billion in U.S. research and manufacturing in the coming years, joining other drugmakers that have promised to bolster domestic capabilities as they brace for tariffs from the Trump administration. [Johnson & Johnson](https://www.wsj/health/phar

Executive order says if companies and the government don’t align on tying U.S. drug prices to other countries, the administration will impose its own plan.

An executive order says if companies and the government don’t align on tying U.S. drug prices to other countries, the administration will impose its own plan.

The Trump administration on Tuesday said it identified price targets that drugmakers are expected to voluntarily match for their pharmaceuticals, as it seeks to implement [an executive order that ties U.S. drug prices](https://www.wsj/health/pharma/trump-drug-price-plan-pharmaceutical-companies-

Bristol-Myers Squibb Chief Executive Chris Boerner said at The Wall Street Journal's Future of Everything festival on Thursday that potential tariffs targeting the drug industry from the Trump administration must not create supply constraints. Bristol and other drugmakers are bracing for tariffs ta

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to vaccine rules.

President Trump's executive order seeking to tie U.S. drug prices to those abroad could impact future investment in America, the chief executive of pharmaceutical company Roche said. The Swiss company has planned to invest $50 billion the the U.S. over the next five years, one of several big pharma firms that pledged large investments as the possibility of tariffs on the industry loomed. When asked how Trump's order, signed last month and opposed by the industry, could affect such plans, Chief Executive Thomas Schinecker said Roche was in discussion with the government.